An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
Clinical trial NCT02828046 · COMPLETED
Trial details
- NCT number
- NCT02828046
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2017-08-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.